Literature DB >> 21805120

Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV).

Beth Wadsworth1, Jeffery M Bumpous, Alvin W Martin, Michael R Nowacki, Alfred B Jenson, Hanan Farghaly.   

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is an uncommon and highly aggressive neoplasm of the paranasal sinuses and nasal cavity. Its undifferentiated histologic appearance often requires immunohistochemical studies to distinguish it from other high-grade neoplasms. Due to the rarity of SNUC, its immunohistochemical staining profile has been incompletely characterized, and little work has been done on its expression of the markers for human papillomavirus (HPV). Our objective is to expand our knowledge of its immunophenotype and its association with HPV in order to define markers with mechanistic potential in the disease process, or of possible therapeutic importance. A total of five patients (one woman and four men) with SNUC, ranging in age from 26 to 75 years (mean 56.8 years) were compared to five patients (five men) with poorly differentiated squamous cell carcinoma (PDSCC), ranging in age from 53 to 75 years (mean 62.2 years). PDSCC was chosen as a control, given its well-reported immunohistochemical profile and negativity for HPV markers. The immunohistochemical panel included: CK7, CK19, EMA, NSE, chromogranin, p53, CK5/6, p63, CK14, S100, HMB-45, desmin, muscle specific actin, and CD45. Additionally, tests for p16, EBV, and HPV (subtypes 6, 11 16, 18) were performed. The diagnosis of SNUC was confirmed in all cases by histology and immunohistochemical stains. An interesting finding of strong diffuse positivity for p16 was noted in all SNUC cases, compared to only two of five PDSCC that were positive for p16. HPV DNA was not detected in any SNUC cases or any cases of PDSCC. All SNUC cases demonstrated over expression of p16 in the absence of HPV DNA expression. This may represent residual epithelial p16 staining, which is normally present in the sinonasal tract. Due to the rarity of SNUC, more cases will need to be evaluated to confirm the absence of HPV DNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805120      PMCID: PMC3210220          DOI: 10.1007/s12105-011-0285-8

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  30 in total

Review 1.  The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.

Authors:  C C R Ragin; F Modugno; S M Gollin
Journal:  J Dent Res       Date:  2007-02       Impact factor: 6.116

Review 2.  Survey of sinonasal inverted papillomata for Epstein-Barr virus.

Authors:  S T Dunn; G D Clark; T C Cannon; K W Min
Journal:  Head Neck       Date:  1997-03       Impact factor: 3.147

Review 3.  Human papillomavirus and head and neck cancer: epidemiology and molecular biology.

Authors:  R G McKaig; R S Baric; A F Olshan
Journal:  Head Neck       Date:  1998-05       Impact factor: 3.147

Review 4.  The tumor suppressor protein p16INK4a.

Authors:  M Serrano
Journal:  Exp Cell Res       Date:  1997-11-25       Impact factor: 3.905

5.  Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity.

Authors:  Samir K El-Mofty; Danielle W Lu
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

6.  Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma.

Authors:  C H Rassekh; P L Rady; I Arany; S K Tyring; S Knudsen; K H Calhoun; H Seikaly; B J Bailey
Journal:  Laryngoscope       Date:  1998-03       Impact factor: 3.325

7.  The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.

Authors:  T Major; K Szarka; I Sziklai; L Gergely; J Czeglédy
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

8.  A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.

Authors:  E Blair Holladay; Sarah Logan; Jeffrey Arnold; Brad Knesel; G Denice Smith
Journal:  Cancer       Date:  2006-12-25       Impact factor: 6.860

9.  Case-control study of human papillomavirus and oropharyngeal cancer.

Authors:  Gypsyamber D'Souza; Aimee R Kreimer; Raphael Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

10.  Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.

Authors:  H F Frierson; S E Mills; R E Fechner; J B Taxy; P A Levine
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394

View more
  13 in total

1.  p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.

Authors:  Llucia Alos; Sofia Hakim; Ana-Belen Larque; Jorge de la Oliva; Leonardo Rodriguez-Carunchio; Miguel Caballero; Alfons Nadal; Carles Marti; Nuria Guimera; Maria-Teresa Fernandez-Figueras; Wim Quint; Jaume Ordi
Journal:  Virchows Arch       Date:  2016-07-08       Impact factor: 4.064

Review 2.  Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution Experience.

Authors:  Alan D Workman; Robert M Brody; Edward C Kuan; Esther Baranov; Steven G Brooks; Michelle Alonso-Basanta; Jason G Newman; Christopher H Rassekh; Ara A Chalian; Alexander G Chiu; Gregory S Weinstein; Michael D Feldman; Nithin D Adappa; Bert W O'Malley; James N Palmer
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-16

Review 4.  The sinonasal tract: another potential "hot spot" for carcinomas with transcriptionally-active human papillomavirus.

Authors:  James S Lewis; William H Westra; Lester D R Thompson; Leon Barnes; Antonio Cardesa; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Asterios Triantafyllou; Julia A Woolgar; Kenneth O Devaney; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2013-12-14

Review 5.  HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients.

Authors:  Max Robinson; Andrew Schache; Philip Sloan; Selvam Thavaraj
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 6.  p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma.

Authors:  James S Lewis
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 7.  Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review.

Authors:  Tatyana Isayeva; Yufeng Li; Daniel Maswahu; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2012-07-03

8.  A novel prediction model for human papillomavirus-associated oropharyngeal squamous cell carcinoma using p16 and subcellular β-catenin expression.

Authors:  Guoqing Qian; Zhongliang Hu; Hong Xu; Susan Müller; Dongsheng Wang; Hongzheng Zhang; Sungjin Kim; Zhengjia Chen; Nabil F Saba; Dong M Shin; Andrew Y Wang; Zhuo Georgia Chen
Journal:  J Oral Pathol Med       Date:  2015-10-22       Impact factor: 4.253

Review 9.  Oropharyngeal Mixed Neuroendocrine-Nonneuroendocrine Neoplasm (MiNEN): A Case Report and Literature Review.

Authors:  Liam Robinson; Ciska-Mari Schouwstra; Willie F P van Heerden
Journal:  Head Neck Pathol       Date:  2021-03-11

Review 10.  SMARCB1/INI1 Deficient Sino-Nasal Carcinoma: Extending the Histomorphological Features.

Authors:  Pavithra Ayyanar; Pritinanda Mishra; Chappity Preetam; Amit Kumar Adhya
Journal:  Head Neck Pathol       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.